Tower Research Capital (TRC)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,672
Closed -$31K 6345
2023
Q3
$31K Sell
1,672
-11,040
-87% -$125K ﹤0.01% 2994
2023
Q2
$141K Buy
12,712
+2,739
+27% +$38.2K ﹤0.01% 1802
2023
Q1
$134K Buy
9,973
+97
+1% +$1.68K ﹤0.01% 1623
2022
Q4
$122K Sell
9,876
-27,496
-74% -$389K 0.01% 1680
2022
Q3
$521K Buy
37,372
+28,953
+344% +$466K 0.01% 1108
2022
Q2
$116K Buy
8,419
+4,457
+112% +$71.4K ﹤0.01% 2178
2022
Q1
$64K Sell
3,962
-3,576
-47% -$56K ﹤0.01% 2543
2021
Q4
$123K Sell
7,538
-8,535
-53% -$144K ﹤0.01% 2094
2021
Q3
$239K Buy
16,073
+13,361
+493% +$214K 0.01% 1645
2021
Q2
$54K Buy
2,712
+461
+20% +$9.14K ﹤0.01% 2976
2021
Q1
$52K Sell
2,251
-7,561
-77% -$211K ﹤0.01% 3097
2020
Q4
$242K Buy
9,812
+7,794
+386% +$258K 0.01% 1573
2020
Q3
$84K Sell
2,018
-1,938
-49% -$89K ﹤0.01% 3284
2020
Q2
$189K Buy
+3,956
New +$306K 0.01% 1836
2019
Q4
Sell
-550
Closed -$36K 4594
2019
Q3
$36K Buy
+550
New +$36.9K ﹤0.01% 2032
2019
Q2
Sell
-162
Closed -$18K 4480
2019
Q1
$18K Sell
162
-97
-37% -$10.6K ﹤0.01% 2340
2018
Q4
$26K Buy
259
+160
+162% +$16.6K ﹤0.01% 1750
2018
Q3
$13K Buy
+99
New +$10.5K ﹤0.01% 2620
2018
Q2
Sell
-1,916
Closed -$118K 4188
2018
Q1
$118K Buy
1,916
+880
+85% +$53K 0.01% 1160
2017
Q4
$61K Buy
1,036
+258
+33% +$16.3K 0.01% 1186
2017
Q3
$45K Buy
778
+650
+508% +$70K ﹤0.01% 2065
2017
Q2
$15K Buy
128
+86
+205% +$9.96K ﹤0.01% 1383
2017
Q1
$5K Sell
42
-169
-80% -$19.7K ﹤0.01% 2245
2016
Q4
$23K Buy
211
+155
+277% +$18.5K ﹤0.01% 2027
2016
Q3
$9K Sell
56
-85
-60% -$13.4K ﹤0.01% 2166
2016
Q2
$20K Sell
141
-705
-83% -$103K ﹤0.01% 2246
2016
Q1
$109K Buy
+846
New +$99.9K 0.02% 477
2015
Q3
Sell
-52
Closed -$13K 4981
2015
Q2
$13K Buy
+52
New +$13.8K ﹤0.01% 2486
2014
Q4
Sell
-7
Closed -$2K 4856
2014
Q3
$2K Buy
+7
New +$1.78K ﹤0.01% 3901
2014
Q1
Sell
-1,146
Closed -$78K 5062
2013
Q4
$78K Buy
1,146
+785
+217% +$45.4K 0.01% 1006
2013
Q3
$25K Sell
361
-161
-31% -$7.95K ﹤0.01% 2519
2013
Q2
$23K Buy
+522
New +$17.8K ﹤0.01% 1583